CIK 0001681682 · Non-accelerated filer<br>Smaller reporting company
ENDRA Life Sciences Inc.
Sign in to watch- Ticker
- NDRA
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 260579295
- Phone
- 734-335-0468
- Business address
- 3600 GREEN COURT, SUITE 350, ANN ARBOR, MI, 48105
- Former names
- Endra Inc.
- 8-K Event Delisting notice · Shareholder vote results
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Option exercise Director acquired 100,503 shares (option exercise)
- 8-K Event Other events
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Option exercise Chief Technology Officer acquired 26,000 shares (option exercise)
- 4 Option exercise Director acquired 5,000 shares (option exercise)
- 4 Option exercise Chief Financial Officer acquired 5,000 shares (option exercise)
- 4 Option exercise Chief Executive Officer acquired 2,874 shares (option exercise)
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- 4 Conversion Director acquired 11,386 shares (conversion)
- 4 Conversion Chief Financial Officer acquired 10,350 shares (conversion)
- 4 Conversion Chief Technology Officer acquired 51,747 shares (conversion)
- 4 Conversion Chief Executive Officer acquired 5,175 shares (conversion)
- 4 Open-market buy Director bought 5,000 shares at $0.92 ($4,600)
- 8-K Event Regulation FD disclosure
- 4 Open-market buy Director bought 10,000 shares at $0.90 ($9,000)
Page 16 of 28 · 547 filings